The Ozempic effect has battered this weight loss stock, but Morgan Stanley says it’s a top pick
Game-changing anti-obesity medications have posed nothing short of an existential crisis for Weight Watchers parent WW International since they arrived on the scene, but CEO Sima Sistani has…
Read more The Ozempic effect has battered this weight loss stock, but Morgan Stanley says it’s a top pick